As Democrats hammer out the Build Back Better legislation some are worried that the drug price provision may have an adverse impact on cancer patients. Ted Okon, executive director of the Community Oncology Alliance, says his oranization is lobbying Senator Tom Carper to make changes in the bill.
Oncology Group Urges Delaware Senator to Change Drug Pricing Provision
Logo
